To enhance the removal of ciprofloxacin (CIP, 1000–10,000 μg/L) in pharmaceutical wastewater, an efficient CIP-degrading bacterium, Paraclostridium sp. (strain S2), was immobilized and added into a sulfate-reducing up-flow sludge bed (SRUSB) bioreactor during long-term operation (over 80 days). CIP removal was increased by 18.7 % in the bioaugmented bioreactor with immobilized strain S2 compared to that in the control bioreactor under high CIP concentration (i.e., 10,000 μg/L), and the acute toxicity of the effluent in the bioaugmented bioreactor was significantly decreased by 81.1 % compared to that of the control. These results were attributed to the specific adaptability of strain S2 to environments via the alteration of its microbial physiology (e.g., extracellular polymeric substance (EPS) secretion, membrane permeability, cell surface charge, and hydrophobicity), which ensured its sustainability in the bioreactor, thus enhancing CIP removal. This study presents a novel biotechnology for CIP-contaminated wastewater treatment via the bioaugmentation by strain S2.
Read full abstract